BioCentury
ARTICLE | Company News

A&G, Celltrion deal

June 12, 2006 7:00 AM UTC

Celltrion will manufacture preclinical and clinical batches of A&G's anti-GP88 monoclonal antibody, which is in preclinical development for cancer. Also, Celltrion received exclusive commercialization...